Blockchain Registration Transaction Record

Cardio Diagnostics Revolutionizes Heart Health with AI-Powered Genetic Analysis

Cardio Diagnostics uses AI, genetics & epigenetics to transform cardiovascular disease prevention & detection. NASDAQ: CDIO company creates personalized heart health insights.

This development matters because cardiovascular disease remains the leading cause of death globally, claiming approximately 17.9 million lives annually according to World Health Organization data. Traditional cardiovascular risk assessment methods often rely on indirect indicators like cholesterol levels and blood pressure, which may not capture individual genetic predispositions or environmental influences. Cardio Diagnostics' approach could enable earlier, more accurate detection of cardiovascular risks before symptoms appear, potentially preventing heart attacks and strokes through personalized interventions. For patients, this means more targeted prevention strategies based on their unique molecular profile rather than one-size-fits-all recommendations. For healthcare systems, improved early detection could reduce the enormous economic burden of cardiovascular disease treatment, estimated at over $350 billion annually in the United States alone. The integration of epigenetics adds crucial insight into how lifestyle and environmental factors modify genetic risk over time, creating a dynamic understanding of cardiovascular health that evolves with the patient.